1don MSNOpinion
Trump's Marijuana Order Vindicates Longstanding Criticism of the Plant's Legal Classification
Under Trump's executive order, marijuana will be moved from Schedule I, which includes banned substances such as heroin, LSD, ...
SEOUL (Reuters) -- South Korea's Samsung Biologics said on Monday it is acquiring its first U.S. drug production facility from GSK for $280 million to respond to long-term U.S. market demand.
Claims that poinsettias can cause serious health problems or death in pets greatly exaggerate their risk, experts say.
Samsung Biologics has entered into a definitive agreement to acquire 100% of Human Genome Sciences from GSK, securing its first U.S.-based ...
Native along the entire East Coast and west to Missouri and Texas, this slow-growing, pyramidical holly can reach 25-60 feet tall at maturity. Also known as Christmas holly, the spiny-leaved plants ...
Eli Lilly is investing $6B in a Huntsville, Ala., plant to make weight-loss and other medicines. Here’s what we know about jobs and timeline.
Mo Khalil is the Hok Lam and Kathleen Kam Wong Professor of Bioengineering and Professor of Molecular and Cellular Biology at ...
President Donald Trump has directed his administration to pursue reclassifying marijuana as a less dangerous drug.
Money Talks News on MSN
Hair loss treatment gets major upgrade using natural plant-based sweetener
Researchers created a breakthrough hair loss treatment using kitchen sweetener stevioside that could make baldness drugs like ...
President Donald Trump has signed an executive order that could reclassify marijuana as a less dangerous drug.
Located in Rockville, Maryland, GSK's Human Genome Sciences will be Samsung Biologics' first U.S.-based manufacturing site. | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results